Bruker Forensic
April 2022

The emergence of new psychoactive substances (NPS), or designer drugs, is a continuing issue for drug enforcement agencies. These drugs are designed to mimic the effects of controlled substances but circumvent controlled substances legislation with a slightly modified novel chemical structure.

Bruker is striving to discover together how to support the combat against illegal drugs

An Integrated Approach to Identifying NPS

In the EU, the Joint Research Centre of the European Commission is responsible for identifying unknown substances seized by customs. And to help advance the rapid identification of NPS. The team explored how integrating information from different techniques and instruments can be used to achieve full analytical confirmation of a new unknown substance.

NMR Helps Tackle Scourge of Designer Drugs

A recent study by researchers from the Technische Universität Braunschweig (Ernst et al. 2019) used Nuclear magnetic Resonance (NMR) to characterize a newly described NPS prevalent in drug samples purchased online.